132 related articles for article (PubMed ID: 12704856)
1. Maternal serum markers in pregnancies associated with fetal trisomy 21 of native Japanese women with or without fetal morphological abnormalities.
Hoshi N
Hokkaido Igaku Zasshi; 2003 Mar; 78(2):139-45. PubMed ID: 12704856
[No Abstract] [Full Text] [Related]
2. [Reevaluation of maternal serum marker test as prenatal diagnosis in Japanese pregnant women].
Hattori R
Hokkaido Igaku Zasshi; 2003 Mar; 78(2):129-38. PubMed ID: 12704855
[No Abstract] [Full Text] [Related]
3. Efficacy of maternal serum screening in the prenatal detection of fetal chromosome abnormalities in Japanese women.
Kishida T; Hoshi N; Hattori R; Negishi H; Yamada H; Okuyama K; Hanatani K; Takagi T; Sagawa T; Fujimoto S
Fetal Diagn Ther; 2000; 15(2):112-7. PubMed ID: 10720877
[TBL] [Abstract][Full Text] [Related]
4. Screening of trisomy 21.
De Biasio P; Canini S; Famularo L; Santi F
J Perinat Med; 1994; 22 Suppl 1():18-21. PubMed ID: 7523651
[No Abstract] [Full Text] [Related]
5. Effect of gravidity and parity on the parameters used in serum screening for trisomy 21.
Zimmermann R; Streicher A; Huch R; Huch A
Prenat Diagn; 1995 Aug; 15(8):781-2. PubMed ID: 7479601
[No Abstract] [Full Text] [Related]
6. Dimeric inhibin A as a fourth marker for Down's syndrome maternal serum screening in native Japanese women.
Yoshida K; Kuwabara Y; Tanaka T; Onda T; Kudo R; Yamamoto H; Sato A; Yanagida K; Okai T; Sakai M; Takai Y; Uemura H; Hoshi K; Fukada Y; Aono T; Maeda K; Ogita S; Ishiko O; Murata Y; Kanzaki T; Myrick F; Grier RE
J Obstet Gynaecol Res; 2000 Jun; 26(3):171-4. PubMed ID: 10932977
[TBL] [Abstract][Full Text] [Related]
7. Triple marker screening in native Japanese women.
Onda T; Kitagawa M; Takeda O; Sago H; Kubonoya K; Iinuma K; Bradley LA; Canick JA; Krasikov NE; Ponting NR; Grier RE
Prenat Diagn; 1996 Aug; 16(8):713-7. PubMed ID: 8878280
[TBL] [Abstract][Full Text] [Related]
8. A prospective trial of prenatal screening for Down syndrome by means of maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol.
Burton BK; Prins GS; Verp MS
Am J Obstet Gynecol; 1993 Sep; 169(3):526-30. PubMed ID: 7690522
[TBL] [Abstract][Full Text] [Related]
9. Prenatal screening for Down's syndrome with use of maternal serum markers.
Haddow JE; Palomaki GE; Knight GJ; Williams J; Pulkkinen A; Canick JA; Saller DN; Bowers GB
N Engl J Med; 1992 Aug; 327(9):588-93. PubMed ID: 1379344
[TBL] [Abstract][Full Text] [Related]
10. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
[TBL] [Abstract][Full Text] [Related]
11. Triple marker screening for trisomy 21, trisomy 18 and open neural tube defects in singleton pregnancies of native Japanese pregnant women.
Onda T; Tanaka T; Yoshida K; Nakamura Y; Kudo R; Yamamoto H; Sato A; Yanagida K; Takai Y; Uemura H; Hoshi K; Fukada Y; Miyake Y; Ohnishi M; Kaneoka T; Makino Y; Murata Y; Kanzaki T; Kanzaki H; Osaki T; Aono T; Maeda K; Ogita S; Yamamasu S; Aso T; Shimizu Y; Izutsu T; Kudo T; Okai T; Sakai M; Hashimoto T; Matsuzaki N; Kitagawa M; Sago H; Grier RE; Myrick F; Shimizu Y
J Obstet Gynaecol Res; 2000 Dec; 26(6):441-7. PubMed ID: 11152330
[TBL] [Abstract][Full Text] [Related]
12. Elevated maternal serum alpha-fetoprotein, very low unconjugated oestriol, and very low human chorionic gonadotropin associated with recent fetal death.
Walters CP; McKinnon WC
Prenat Diagn; 1993 May; 13(5):423-4. PubMed ID: 7688120
[No Abstract] [Full Text] [Related]
13. Maternal serum screening for Down syndrome before 15 weeks.
Cuckle H; Lilford R; Jones R
Am J Obstet Gynecol; 1994 Mar; 170(3):959. PubMed ID: 7511335
[No Abstract] [Full Text] [Related]
14. Triple marker (alpha-fetoprotein, unconjugated estriol, human chorionic gonadotropin) versus alpha-fetoprotein plus free-beta subunit in second-trimester maternal serum screening for fetal Down syndrome: a prospective comparison study.
Kellner LH; Weiner Z; Weiss RR; Neuer M; Martin GM; Mueenuddin M; Bombard A
Am J Obstet Gynecol; 1995 Oct; 173(4):1306-9. PubMed ID: 7485343
[TBL] [Abstract][Full Text] [Related]
15. Maternal serum screening for alpha-fetoprotein, unconjugated estriol, and human chorionic gonadotropin between 11 and 15 weeks of pregnancy to detect fetal chromosome abnormalities.
Crandall BF; Hanson FW; Keener S; Matsumoto M; Miller W
Am J Obstet Gynecol; 1993 Jun; 168(6 Pt 1):1864-7; discussion 1867-9. PubMed ID: 7686337
[TBL] [Abstract][Full Text] [Related]
16. The implications of a false positive second-trimester serum screen for Down syndrome.
Summers AM; Huang T; Meier C; Wyatt PR
Obstet Gynecol; 2003 Jun; 101(6):1301-6. PubMed ID: 12798540
[TBL] [Abstract][Full Text] [Related]
17. Second trimester total human chorionic gonadotropin, alpha-fetoprotein and unconjugated estriol in predicting pregnancy complications other than fetal aneuploidy.
Duric K; Skrablin S; Lesin J; Kalafatic D; Kuvacic I; Suchanek E
Eur J Obstet Gynecol Reprod Biol; 2003 Sep; 110(1):12-5. PubMed ID: 12932863
[TBL] [Abstract][Full Text] [Related]
18. Pregnancy hormone levels signal trisomy 21, improved screening, lower costs possible.
Randall T
JAMA; 1991 Apr; 265(14):1797-8. PubMed ID: 1706442
[No Abstract] [Full Text] [Related]
19. [Triple screening for trisomy 21: prospective results of 7039 assessments].
Pescia G; Dao MH; Weihs D; Gaide AC; Loertscher A; Hohlfeld P; Marguerat P; Nguyen The H; Paccaud F; Maillard C
Rev Med Suisse Romande; 1993 Apr; 113(4):277-80. PubMed ID: 7684852
[No Abstract] [Full Text] [Related]
20. Screening for Down syndrome at 14 weeks of pregnancy.
Wald NJ; Watt HC; Haddow JE; Knight GJ
Prenat Diagn; 1998 Mar; 18(3):291-3. PubMed ID: 9556047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
